High Initial-dose Dependency of Cerebrovascular Disease Mortality among Female Survivors of the Hiroshima Atomic Bomb Exposed in Teens: A Cohort Study, 1970-2010
- PMID: 29989683
High Initial-dose Dependency of Cerebrovascular Disease Mortality among Female Survivors of the Hiroshima Atomic Bomb Exposed in Teens: A Cohort Study, 1970-2010
Abstract
Several studies have been conducted on cerebrovascular disease mortality in Atomic bomb survivors. Previous studies have investigated the relationship between mortality and initial radiation dose after adjusting for the effects of sex and age at the time of the bombing (ATB), and detected a weak (but statistically significant) dose-response relationship was detected. The objective of the present study was to examine whether the sex- and age ATB-specific cerebrovascular disease mortality among Hiroshima atomic bomb survivors can be explained by the initial radiation dose. At Hiroshima University, a cohort study has been conducted with Hiroshima Atomic Bomb Survivors (ABS) since 1970. We selected 30,378 subjects from the ABS who were exposed at 3.5 km or less from the hypocenter and still alive on January 1, 1970. These subjects were followed up until December 31, 2010. The cohort data were stratified with respect to sex and age ATB into 10-year age groups. For each stratum, using Cox regression, we performed survival analyses of the risk of cerebrovascular mortality using the initial radiation dose and the exposure distance (the ground distance between the exposure location and the hypocenter) as explanatory variables. The results indicated that the risks to females exposed at 10 to 19 years old were highly dependent on the initial radiation dose (hazard ratio: 1.51, p < 0.001), while the risks to males were not. There might exist some radiation exposure effects limited to women who were in their teens at the time of exposure. However, the background mechanisms remain unclear, necessitating further study.
Similar articles
-
High Excess Risk of Heart Disease Mortality among Hiroshima Atomic Bomb Male Survivors Exposed Near the Hypocenter.Hiroshima J Med Sci. 2016 Sep;65(2):45-51. Hiroshima J Med Sci. 2016. PMID: 29989684
-
Thyroid Dysfunction and Autoimmune Thyroid Diseases Among Atomic Bomb Survivors Exposed in Childhood.J Clin Endocrinol Metab. 2017 Jul 1;102(7):2516-2524. doi: 10.1210/jc.2017-00102. J Clin Endocrinol Metab. 2017. PMID: 28472357
-
Risk of death among children of atomic bomb survivors after 62 years of follow-up: a cohort study.Lancet Oncol. 2015 Oct;16(13):1316-23. doi: 10.1016/S1470-2045(15)00209-0. Epub 2015 Sep 14. Lancet Oncol. 2015. PMID: 26384241
-
Cancer and non-cancer effects in Japanese atomic bomb survivors.J Radiol Prot. 2009 Jun;29(2A):A43-59. doi: 10.1088/0952-4746/29/2A/S04. Epub 2009 May 19. J Radiol Prot. 2009. PMID: 19454804 Review.
-
Workshop Report on Atomic Bomb Dosimetry--Review of Dose Related Factors for the Evaluation of Exposures to Residual Radiation at Hiroshima and Nagasaki.Health Phys. 2015 Dec;109(6):582-600. doi: 10.1097/HP.0000000000000395. Health Phys. 2015. PMID: 26509626 Review.